Essais liés4clinical trials
VilleEskişehirlocalisation
PaysTurkey (Türkiye)localisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT06585787

Ouvrir le site du centre

Essais cliniques associés

4
MoléculeIndication / populationPhaseNCTTitreStatut
KarXT Alzheimer Phase 3 NCT06585787 A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4) RECRUITING
Eptinezumab Migraine Phase 3 NCT05897320 PROSPECT-1 — A Study of Eptinezumab in Pediatric Participants With Episodic Migraine RECRUITING
Eptinezumab Migraine Phase 3 NCT05164172 REJOIN — A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine RECRUITING
Eptinezumab Migraine Phase 3 NCT04965675 PROSPECT-2 — A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine RECRUITING